| Strategies for glycoengineering therapeutic proteins K Dammen-Brower, P Epler, S Zhu, ZJ Bernstein, PR Stabach, ... Frontiers in Chemistry 10, 863118, 2022 | 26 | 2022 |
| Modular complement assemblies for mitigating inflammatory conditions KM Hainline, LS Shores, NL Votaw, ZJ Bernstein, SH Kelly, CN Fries, ... Proceedings of the National Academy of Sciences 118 (15), e2018627118, 2021 | 20 | 2021 |
| Multiepitope supramolecular peptide nanofibers eliciting coordinated humoral and cellular antitumor immune responses Y Wu, H Wen, ZJ Bernstein, KM Hainline, TS Blakney, KL Congdon, ... Science Advances 8 (29), eabm7833, 2022 | 15 | 2022 |
| Engineering the IL‐4/IL‐13 axis for targeted immune modulation ZJ Bernstein, A Shenoy, A Chen, NM Heller, JB Spangler Immunological reviews 320 (1), 29-57, 2023 | 11 | 2023 |
| Insights into the anticancer mechanisms of interleukin-15 from engineered cytokine therapies ZJ Bernstein, JB Spangler The Journal of Clinical Investigation 131 (19), 2021 | 6 | 2021 |
| Design of cell-type-specific hyperstable IL-4 mimetics via modular de novo scaffolds H Yang, UY Ulge, A Quijano-Rubio, ZJ Bernstein, DR Maestas, JH Chun, ... Nature chemical biology 19 (9), 1127-1137, 2023 | 5 | 2023 |
| A versatile design platform for glycoengineering therapeutic antibodies SD Ludwig, ZJ Bernstein, C Agatemor, K Dammen-Brower, J Ruffolo, ... Mabs 14 (1), 2095704, 2022 | 1 | 2022 |
| Engineering Glycans into Antibody Fab Domains for Improved Therapeutic Efficacy Z Bernstein, S Ludwig, C Agatemor, K Yarema, J Spangler 2021 AIChE Annual Meeting, 2021 | | 2021 |
